Disease Control Data, nr-axSpA

Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.

Extra-articular manifestations and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis.

JCM, Free Full-Text

A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy

The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort

Understanding Axial Spondyloarthritis: A Primer for Managed Care

Abbreviations AS: ankylosing spondylitis; ASAS: Assessment of

Association of circulating calprotectin with lipid profile in axial spondyloarthritis

Disease Control Data, nr-axSpA

PDF) Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: Data from a large, prospective, observational cohort

Understanding Axial Spondyloarthritis: A Primer for Managed Care

Comparison of clinical characteristics between adult-onset and juvenile-onset non-radiographic axial spondyloarthritis in Chinese patients: results from the COCAS cohort, European Journal of Medical Research